RxDoctor Payments Data

Teresa Olson, MD

Family Medicine · Lexington, SCNPI 1619953015

Payments from drug & device makers

$634in general payments, 2019–2025

Across 41 payments — averaging $15.46 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$137
  • Amarin Pharma, Inc.$111
  • Lilly USA, LLC$106
  • Merck$66
  • Boehringer Ingelheim$47
  • Exact Sciences$36
  • plus $130 from 6 others

What the payments were for

  • Food & beverage$634100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$634 in reported general payments places this provider in the 50th percentile of 2,153 family medicine providers in South Carolina.

See all family medicine providers in South Carolina

Medicare billing

Part B allowed, 2024
$72,953
Medicare patients
179
Services billed
1,118

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide30$55,078
OzempicSemaglutide27$35,192
JardianceEmpagliflozin14$22,349
FarxigaDapagliflozin Propanediol21$18,974
JanuviaSitagliptin Phosphate12$18,512
EliquisApixaban18$17,752
MyrbetriqMirabegron14$13,197
Trelegy ElliptaFluticasone/Umeclidin/Vilanter11$7,257
Lantus SolostarInsulin Glargine,hum.Rec.Anlog12$2,469
Rosuvastatin Calcium105$2,436
Famotidine125$2,260
Albuterol Sulfate HfaAlbuterol Sulfate54$1,672
Duloxetine Hcl42$1,319
Atorvastatin Calcium121$1,306
Losartan Potassium125$1,152

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro$106$55,07830 claims
Novo NordiskOzempic$27$35,19227 claims
Boehringer IngelheimJardiance$47$22,34914 claims
AstraZenecaFarxiga$137$18,97421 claims
MerckJanuvia$66$18,51212 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 2,153 family medicine providers in South Carolina.

Other family medicine in Lexington

See the full list for South Carolina

Where these figures come from

Is this you, or does something look wrong? →